Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on Sarcopenia

Beitrag in einer Fachzeitschrift


Details zur Publikation

Autorinnen und Autoren: Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, Van Kan GA, Andrieu S, Bauer J, Breuille D, Cederholm T, Chandler J, De Meynard C, Donini L, Harris T, Kannt A, Guibert FK, Onder G, Papanicolaou D, Rolland Y, Rooks D, Sieber C, Souhami E, Verlaan S, Zamboni M
Zeitschrift: Journal of the American Medical Directors Association
Verlag: ELSEVIER SCIENCE INC
Jahr der Veröffentlichung: 2011
Band: 12
Heftnummer: 4
Seitenbereich: 249-256
ISSN: 1525-8610


Abstract

Sarcopenia, the age-associated loss of skeletal muscle mass and function, has considerable societal consequences for the development of frailty, disability, and health care planning. A group of geriatricians and scientists from academia and industry met in Rome, Italy, on November 18, 2009, to arrive at a consensus definition of sarcopenia. The current consensus definition was approved unanimously by the meeting participants and is as follows: Sarcopenia is defined as the age-associated loss of skeletal muscle mass and function. The causes of sarcopenia are multifactorial and can include disuse, altered endocrine function, chronic diseases, inflammation, insulin resistance, and nutritional deficiencies. Although cachexia may be a component of sarcopenia, the 2 conditions are not the same. The diagnosis of sarcopenia should be considered in all older patients who present with observed declines in physical function, strength, or overall health. Sarcopenia should specifically be considered in patients who are bedridden, cannot independently rise from a chair, or who have a measured gait speed less that 1 m/s(-1). Patients who meet these criteria should further undergo body composition assessment using dual energy x-ray absorptiometry with sarcopenia being defined using currently validated definitions. A diagnosis of sarcopenia is consistent with a gait speed of less than 1 m.s(-1) and an objectively measured low muscle mass (eg, appendicular mass relative to ht(2) that is <= 7.23 kg/m(2) in men and <= 5.67 kg/m(2) in women). Sarcopenia is a highly prevalent condition in older persons that leads to disability, hospitalization, and death. (J Am Med Dir Assoc 2011; 12: 249-256)


FAU-Autorinnen und Autoren / FAU-Herausgeberinnen und Herausgeber

Bauer, Jürgen PD Dr.
Lehrstuhl für Psychogerontologie
Sieber, Cornel Prof. Dr.
Lehrstuhl für Innere Medizin (Geriatrie)


Einrichtungen weiterer Autorinnen und Autoren

Boston University
Catholic University of the Sacred Heart / Università Cattolica del Sacro Cuore
Centre Hospitalier Universitaire (CHU) de Toulouse
Chiesi France
Danone Nutricia Research
GlaxoSmithKline Research and Development
Merck Sharp & Dohme Corp
National Institute for Health and Medical Research / Institut national de la santé et de la recherche médicale (INSERM)
National Institute on Aging (NIA)
Nestlé S.A.
Novartis Institutes for BioMedical Research, Inc.
Saint Louis University (SLU)
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Groupe
Servier
Università degli studi "La Sapienza"
University of Pittsburgh
University of Verona / Università degli Studi di Verona
Uppsala University

Zuletzt aktualisiert 2018-14-11 um 09:23